Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts.

Authors :: Tabarroki A
Saunthararajah Y
Visconte V
Cinalli T
Colaluca K
Rogers HJ
Sekeres MA
Duong HK
Stein BL
Tiu RV
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2015 Feb; Vol. 56 (2), pp. 497-9. Date of Electronic Publication: 2014 May 27.
Publication Year :: 2015

Subjects :: Aged, 80 and over
Azacitidine administration & dosage
Azacitidine analogs & derivatives
DNA Modification Methylases antagonists & inhibitors
Decitabine
Fatigue prevention & control
Female
Follow-Up Studies
Humans
Male
Middle Aged
Nitriles
Primary Myelofibrosis pathology
Pyrazoles administration & dosage
Pyrimidines
Remission Induction
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Primary Myelofibrosis drug therapy

Full Text Access

Tools